Treatment with biologics of pregnant patients with rheumatic diseases

Current Opinion in Rheumatology

Volumn 23, Issue 3, 2011, Pages 293-298

  Østensen, Monika ^a   Förger, Frauke ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

biological drugs; pregnancy; rheumatic disease

Indexed keywords

ABATACEPT; ADALIMUMAB; ANTIRHEUMATIC AGENT; CERTOLIZUMAB; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; CROHN DISEASE; DRUG HALF LIFE; DRUG MILK LEVEL; FIRST TRIMESTER PREGNANCY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOMA; MEGACOLON; NONHUMAN; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; ULCERATIVE COLITIS;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; BIOLOGICAL PRODUCTS; CHILD; FEMALE; HUMANS; IMMUNOCONJUGATES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; RHEUMATIC DISEASES; SPERMATOGENESIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955017825     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328344a732     Document Type: Review

References (42)

1. Malek A, Sager R, Zakher A, Schneider H. Transport of immunoglobulinG and its subclasses across the in vitro-perfused human placenta. Am J Obestet Gynecol 1995; 173:760-767.
2. Nesbitt A, Fossati G, Brown D, et al. Effects of structure of conventional anti-TNFs and certolizumab pegol on mode of action in rheumatoid arthritis. Ann Rheum Dis 2007; 66 (Suppl 2):296.
3. Johnson DL, Jones KL, Chambers C. Pregnancy outcomes in women exposed to etanercept: the OTIS autoimmune diseases in pregnancy project. Arthritis Rheum 2008; 58 (Suppl 9):S682.
4. Johnson D, Jones K, Chambers C. Pregnancy outcomes in women exposed to adalimumab. Can J Gastroenterol 2009; 23 (Suppl SA):34.
5. Carter JD, Ladhani A, Ricca LR, et al. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009; 36:635-641.
6. Berthelot JM, De Bandt M, Goupille P, et al. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine 2009; 76:28-34.
7. 1stensen M, Fö rger F, Villiger PM. Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci 2006; 1069:353-363.
8. Yu XW, Yan CF, Jin HL, Li X. Tumor necrosis factor receptor 1 expression and early spontaneous abortion. Int J Gynecol and Obstet 2005; 88: 77-79.
9. Winger EE, Reed JL, Ashoush S, et al. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009; 61:113-120.
10. Sills ES, Walsh DJ, Shkrobot LV, et al. Clinical experience with intravenous immunoglobulin and TNF-a inhibitor therapies for recurrent pregnancy loss. Ulster Med J 2009; 78:57-58.
11. Jerzak M, Niemiec T, Nowakowska A, et al. First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles: case report. Am J Reprod Immunol 2010; 64:93-96.
12. Puig L, Barco D, Alomar A. Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature. Dermatology 2010; 220:71-76.
13. Kane S, Ford J, Cohen R, Wagner C. Absence of Infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol 2009; 43:613-616.
14. Mahadevan U, Terdiman JP, Church J, et al. Infliximab levels in infants born to women with inflammatory bowel disease. Gastroenterology 2007; 132 (Suppl 1):A 144:959.
15. Vasiliauskas EA, Church JA, Silverman, et al. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006; 4:1255-1258. (Pubitemid 44512222)
16. Wang Y, Wang J, Sun Y, et al. Complementary effect of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells. J Immunol 2001; 166:330-337. (Pubitemid 32038449)
17. Cheent K, Nolan J, Shariq S, et al. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohn's Colitis 2010; 4:603-605.
18. Umeda N, Ito S, Hayashi T, et al. A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment. Intern Med 2010; 49:187-189.
19. Rump JA, Schö nborn H. Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment. Z Rheumatol 2010 [Epub ahead of print].
20. Murashima A, Watanabe N, Ozawa N, et al. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum. Ann Rheum Dis 2009; 68:1793-1794.
21. Suzuki T, Ishii-Watabe A, Tada M, et al. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR. J Immunol 2010; 184:1968-1976.
22. Dessinioti C, Stefanaki I, Stratigos A, et al. Pregnancy during adalimumab use for psoriasis. J Eur Acad Dermatol Venereol 2010 [Epub ahead of print].
23. Ben-Horin S, Yavzori M, Katz L, et al. Adalimumab level in breast milk of a nursing mother. Clin Gastroenterol Hepatol 2010; 8:475-476.
24. Oussalah A, Bigard MA, Peyrin-Biroulet L. Certolizumab use in pregnancy. Gut 2009; 58:608.
25. Wolf D, Mahadevan U. Certolizumab pegol use in pregnancy: low levels detected in cord blood. Arthritis Rheum 2010; Nov Suppl, Annual Congress, Abstract 718.
26. Villiger PM, Caliezi G, Cottin V, et al. Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann Rheum Dis 2010; 69:1842-1844.
27. Orencia1 (Abatacept) package insert, Bristol-Myers Squibb, Princeton, NJ, USA; 2009.
28. Pham T, Claudepierre P, Constantin A, et al. Abatacept therapy and safety management. Joint Bone Spine 2009; 76 (S1):S3-S55.
29. MabThera1 (Rituximab) package insert, Roche Pharma, Reinach, Switzerland; 2010.
30. Friedrichs B, Tiemann M, Salwender H, et al. The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006; 91:1426-1427. (Pubitemid 44569825)
31. Decker M, Rothermundt C, Hollä nder G, et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 2006; 7:693-694. (Pubitemid 44123581)
32. Klink DT, Van Elburg RM, Schreurs MWJ, Van Well GTJ. Rituximab administration in third trimester pregnancy suppress neonatal B-cell development. Clin Dev Immunol 2008; 2008:271363.
33. Pellkofer HL, Suessmair C, Schulze A, et al. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Multiple Sclerosis 2009; 15:1006-1008.
34. Rey J, Coso D, Roger V, et al. Rituximab combined with chemotherapy for lymphoma during pregnancy. Leuk Res 2009; 33:e8-e9.
35. Ng CT, O'Neil M, Walsh D, et al. Successful pregnancy after rituximab in a woman with recurrent in vitro fertilisation failures and antiphospholipid antibody. Ir J Med Sci 2009; 178:531-533.
36. Ton E, Tekstra J, Hellman PM, Bijlsma JWJ. Rituximab and pregnancy: safe before conception? A case report and a review of the literature. Ann Rheum Dis 2009; 68 (Abstract AB0229).
37. Ponte P, Lopes MJP. Apparent safe use of a single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy. J Am Acad Dermatol 2010; 63:355-356.
38. Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes following maternal exposure to rituximab. Blood 2010 [Epub ahead of print].
39. Pham T, Fautrel B, Gottenberg JE, et al. Rituximab (MabThera) therapy and safety management. clinical tool guide. Joint Bone Spine 2008; 75 (Suppl 1):S1-S99.
40. Berger CT, Recher M, Steiner U, Hauser TM. A patient's wish: anakinra in pregnancy. Ann Rheum Dis 2009; 68:1794-1795.
41. Actemra1 (Tocilizumab), package insert, Roche Pharma, Reinach, Switzerland; 2010.
42. Rubbert-Roth A, Goupille PM, Moosavi S, Hou A. First experiences with pregnancies in RA patients receiving tocilizumab therapy. Arthritis Rheum 2010; Nov Suppl: Annual Congress, Abstract 384.